$0.3814
-0.0186-4.65%
Last update: Nov 11, 5:58 PM
Lucid Diagnostics Inc
LUCDNASDAQ
Lucid Diagnostics fell 63.3% from $1.04 to $0.38, behind the S&P 500's +9.8%. Its worst day was Oct 19 (−21.0%), and its low came Oct 22 at $0.33.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.10 missed the $-0.08 estimate on $1.2M revenue (est. $1.3M).
+6.7% · S&P 500 +0.1%
Lucid Diagnostics shares rose 13.1%, while the S&P 500 rose 0.0%.
Story events cover the past 12 months · Times ET
+13.1% · S&P 500 0.0%
Lucid Diagnostics closed at its highest level of the year, 41.3% above where the year started.
+0.7% · S&P 500 −0.6%
EPS of $-0.10 missed the $-0.08 estimate on $1.5M revenue (est. $1.3M).
−3.4% · S&P 500 −1.8%
Lucid Diagnostics shares fell 16.8%, while the S&P 500 fell 0.4%.
−16.8% · S&P 500 −0.4%
EPS of $-0.07 missed the $-0.06 estimate on $1.3M revenue (est. $1.4M).
0.0% · S&P 500 +0.8%
Lucid Diagnostics shares rose 15.0%, while the S&P 500 rose 0.4%.
+15.0% · S&P 500 +0.4%
EPS of $-0.08 missed the $-0.05 estimate on $1.5M revenue (est. $1.4M).
−2.0% · S&P 500 +0.7%
Lucid Diagnostics shares fell 15.5%, while the S&P 500 rose 0.2%.
−15.5% · S&P 500 +0.2%
Lucid Diagnostics closed at its lowest level of the year, 68.5% below where the year started.
−1.7% · S&P 500 −1.2%
Where it ended: a close of $0.38 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.06, revenue est. $1.6M).
Nothing in the past 12 months.
All LUCD dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for LUCD and SPY from Benzinga historical bars. Not investment advice.
